Clinical utility of the BREATH score for heart failure risk stratification in patients with atrial fibrillation [0.03%]
用于房颤患者心力衰竭风险分层的BREATH评分的临床应用价值
Yuki Saito,Koichi Nagashima,Daisuke Kitano et al.
Yuki Saito et al.
Background: The BREATH score is a newly developed screening tool for heart failure (HF) with preserved ejection fraction. However, its prognostic value specifically in patients with atrial fibrillation (AF) remains unclea...
Clinical engagement and cardiovascular outcomes of screening-detected atrial fibrillation in working-age adults [0.03%]
筛查发现的工作年龄成人房颤的临床参与和心血管结局
Yuichiro Mori,Shingo Fukuma
Yuichiro Mori
Not all anemia is the same: Distinct in-hospital hemoglobin patterns and prognosis in HFpEF and HFrEF - Insights from the SAKURA-HF registry [0.03%]
并非所有贫血都相同：HFpEF和HFrEF患者住院期间血红蛋白模式及预后的差异——SAKURA-HF注册研究的新见解
Ran Sumida,Daisuke Kitano,Saki Mizobuchi et al.
Ran Sumida et al.
Background: Anemia is common in heart failure (HF), but the prognostic significance of in-hospital hemoglobin (Hb) changes remains unclear. We evaluated whether Hb trajectories during hospitalization for acute HF predict ...
Disease activity is associated with QTc interval in patients with rheumatoid arthritis: Insights from the KURAMA study [0.03%]
日本KURAMA研究中类风湿关节炎患者的疾病活动与QTc间期相关性分析
Xiaoyang Song,Neiko Ozasa,Motomu Hashimoto et al.
Xiaoyang Song et al.
Background: Corrected QT (QTc) prolongation is a frequently observed electrocardiogram (ECG) abnormality in patients with rheumatoid arthritis (RA). In this study, we aimed to investigate the association between disease a...
The impact of the BCIS CHIP score on the prognosis of ischemic acute heart failure [0.03%]
BCIS CHIP评分对急性缺血性心力衰竭预后的影响
Tomofumi Sawatani,Akihiro Shirakabe,Masato Matsushita et al.
Tomofumi Sawatani et al.
Background: The characteristics of acute heart failure (AHF) vary according to ischemic and non-ischemic etiology. Risk stratification of these characteristics by etiology is a pressing issue. ...
Guideline-directed medical therapy and hypotension after initiation of vericiguat: Insights from the VERIFY-HF study [0.03%]
VERIFIC-HF研究中维卡琪格特导致低血压的血管紧张素转换酶抑制剂或血管紧张素受体拮抗剂指导的药物治疗指导方针的见解
Koshiro Kanaoka,Takashi Nakoji,Koki Takegawa et al.
Koshiro Kanaoka et al.
Background: Guidelines recommend vericiguat initiation in patients with heart failure (HF) with reduced ejection fraction who have already been prescribed guideline-directed medical therapy (GDMT). However, few studies ha...
Impact of running average value of non-fasting serum triglyceride for secondary prevention of coronary artery disease [0.03%]
非空腹血清甘油三酯滚动平均值与冠心病二级预防的关系
Ichiro Matsumoto,Kensaku Wada,Mizuki Kurozumi et al.
Ichiro Matsumoto et al.
Background: Elevated non-fasting triglyceride (TG) levels may be associated with increased risk of cardiovascular disease (CVD); however, the best way to measure TG values as an independent risk factor for CVD remains unc...
Hirofumi Ohashi,Atomu Tajima,Koshiro Sakai et al.
Hirofumi Ohashi et al.
Computed tomography-guided percutaneous coronary intervention (CT-guided PCI) represents a new paradigm that extends coronary CT angiography (CCTA) from diagnostic imaging to procedural planning. By integrating morphological and physiologic...